Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma-Reference-Cited by-同舟云学术

Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma

Published:2001-05 Issue:5 Volume:66 Page:328-336
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Gulbrandsen Nina,Wisløff Finn,Nord Erik,Lenhoff Stig,Hjorth Martin,Westin Jan,

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0609.2001.066005328.x/fullpdf

Reference30 articles.

1. Measurement of health related quality of life in multiple myeloma;Wisløff;Br J Haematol,1996

2. Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades;Hjorth;Eur J Haematol,1999

3. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6633 patients from 27 randomized trials;The Myeloma Trialists' Collaborative Group;J Clin Oncol,1998

4. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma;Attal;N Engl J Med,1996

5. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma;Barlogie;Blood,1997

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A head-to-head comparison of the EQ-5D-5L and 15D descriptive systems and index values in a general population sample;Health and Quality of Life Outcomes;2023-02-19

2. Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis;Value in Health;2021-03

3. Cancer drug development: The missing links;Experimental Biology and Medicine;2019-04-08

4. Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results–Medicare Database;Biology of Blood and Marrow Transplantation;2015-10

5. Are high drug prices for hematologic malignancies justified? A critical analysis;Cancer;2015-06-23